Anaphylaxis Clinical Trials

14 recruitingLast updated: May 21, 2026

There are 14 actively recruiting anaphylaxis clinical trials across 10 countries. Studies span Phase 1, Phase 2, Phase 4. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, Berlin, Germany. Updated daily from ClinicalTrials.gov.


Anaphylaxis Trials at a Glance

14 actively recruiting trials for anaphylaxis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Boston, Beijing, and Berlin. Lead sponsors running anaphylaxis studies include Department of Health and Human Services, Tasmanian Government, Dr. George Luciuk, and Charite University, Berlin, Germany.

Browse anaphylaxis trials by phase

About Anaphylaxis Clinical Trials

Looking for clinical trials for Anaphylaxis? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anaphylaxis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anaphylaxis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 1Phase 2

UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Peanut allergyPeanut-Induced Anaphylaxis
Ukko Inc40 enrolled5 locationsNCT07349212
Recruiting
Phase 2

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

antibiotic allergyDrug hypersensitivityCephalosporin Allergy+4 more
Massachusetts General Hospital300 enrolled6 locationsNCT06406114
Recruiting
Phase 1

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

AnaphylaxisHypersensitivity
Dr. George Luciuk100 enrolled1 locationNCT07038746
Recruiting
Phase 4

Steroid Use in Treatment of Allergic Reactions to Food

AnaphylaxisIgE-mediated food allergyAnaphylactic Reaction+1 more
Johannes Trueck160 enrolled2 locationsNCT07341776
Recruiting

Analysis of the Role of IgE Proteoforms in Health and Disease

AnaphylaxisHealthy ControlMastocytosis+6 more
KU Leuven200 enrolled1 locationNCT07328178
Recruiting

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

AnaphylaxisPerioperative/Postoperative ComplicationsTryptase+2 more
Peking University First Hospital115 enrolled5 locationsNCT06793163
Recruiting
Phase 2

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Food allergyPeanut allergyFood Allergy Peanut+3 more
Rima Rachid37 enrolled1 locationNCT05695261
Recruiting

A Registry for the Food Allergy Community

eosinophilic esophagitisAnaphylaxisFood Intolerance+3 more
Food Allergy Research & Education23,000 enrolled1 locationNCT04653324
Recruiting

Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

Anaphylaxis
Charite University, Berlin, Germany20,000 enrolled1 locationNCT05210543
Recruiting
Phase 1

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

Anaphylaxis
Hamad Medical Corporation210 enrolled1 locationNCT03523221
Recruiting

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

Electrolyte disturbanceAnaphylaxisSepsis+16 more
University Medical Center Groningen35,000 enrolled1 locationNCT04615065
Recruiting

MRGPRX2 in general anaesthetic reactions

Anaphylaxis
Melbourne Health60 enrolled1 locationACTRN12618000815268
Recruiting

The Australia and New Zealand Emergency Department Airway Registry (ANZEDAR). A multi-centre observational study of the practice of intubation in the Emergency Department (ED)

Shock due to traumaAltered mental status not due to overdoseStroke/ICH+12 more
Toby Fogg2,500 enrolled30 locationsACTRN12613001052729
Recruiting

Ant Venom Immunotherapy: Improving method and maintenance.

Allergy (anaphylaxis) to the jack jumper ant (JJA)Myrmecia pilosula.
Department of Health and Human Services, Tasmanian Government800 enrolled1 locationACTRN12606000333516